Glucotrack, Inc. entered into an execution copy of a merger agreement with Lohkahi Therapeutics, Inc. dated July 14, 2026. The transaction is subject to customary closing conditions, including regulatory approvals and stockholder approval.
Glucotrack, Inc. entered into an execution copy of a merger agreement with Lohkahi Therapeutics, Inc. dated July 14, 2026. The transaction is subject to customary closing conditions, including regulatory approvals and stockholder approval.